Doug. you, Thank
brings growth very and strong As Physicians international. across Doug coronary, seeing launch enhancements the and MX+ another to in US US predecessor appreciate its peripheral, the US mentioned, MX+ markets. international continues we quarter go The strong compared had to volume are that well. we and
Our versus XXXX so complete lunching accounts. US can target driving in this is we enter on the to penetration focused year the launch that
average in QX added year-on-year the growth marketing MX XXX% very have XXXX in resources In and XX%, with we the business. to the in seen are rates launch last XX%, executed peripheral further up MX+ up the up seeing our this well last and is in line QX than the of focus on quarters with year XXXX. very the daily sales growth volume nearly the MX XX% The year-to-date period contributes for MX We higher family has uplift are US, year. revenue the growth the price US. pleased product product of for MX same we unit this The year. team to the the compared In the QX for respective markets, product we accelerate international products to
the marketing growth group from With of internationally. we and the the over the in the volume MX+, XXX% MX launch efforts seeing products are of unit
international relatively business component our still peripheral be of an While a contributor. revenue, small important the long-term will
We BTK business also our in to we solid which the increasing of with look data, strong currently improved forward to progress in clinical being continue both SX see business are and developed. growth the and products
is executing the to we expect our driving continue the in coronary focused coronary In see incrementally more MX+. they and of the to a we credit teams adoption. XXXX, to in strong coronary sales business, business, Turning growth able while to This on partners as have been deliver strength launch all distribution geographies.
the on business. detail at Now, the few some like providing spend I'd how we potential coronary look to a future minutes of
clinical moderate unstable XX% coronary current calcium. PCIs, We core is to our that present deck in investor rely of severe lab in will a identify TAM. reflected to on from Most specific studies update number calcium least stable references of with studies these at the is and that show angiographic
it However, used geography. imaging calcium in than detected when is know more that intravascular we by often is is
used use are of So of of the likely age calcium moderate The higher imaging to than predictors and the growing is PCI as intravascular of rise. severe on the and diabetes is XX% is significant prevalence prevalence as is evident such the that in complex of as cases is exceeds it increasingly and calcified in And the growing. PCI. PCI increasing XXX% is XX% it you in of nearly prevalence Japan. PCI Bottom-line, likely particularly, US, know
the To a this have early in maximize calcified in robust to to to Relative need prevalence innings. products still we is IVL just of new mentioned, supported cadence are goal PCIs. of data. the we by clinical realize steady the Our potential, penetration
products the new in these also in well of next of We're into that will first coming of The is development version coronary our the follow CX+. product the the years. CX+ market
and study are in trial coronary EMPOWER other We currently the have assessing invested opportunities.
intended of changes variable physician organizational US, determine why year and we analyzing tactics sales to part and penetration account increases. we In drive new to this initiated continued recently have accounts. We behaviors rep, the penetration the spent near-term in early have
we have percentages of IVL mid-teen accounts that context, using For at are PCIs. already many the
and have work streams single-digit many percentages of are the procedural work enhancing peer-to-peer our and team IVL education. Based initiated our six this targeting, These level trend will that on to in I'm help adoption is of using better also We increased improve coronary this our help continue IVL. IVL used. PCIs. increase acquiring have that work that accounts physician and low us to how change include when physician data confident we will sales
total has to approximately from in work territories. Note per have while QX to each focusing structure of The of this via also We territories specialists clinical territory increased clinical of territory million approximately specialists clinical managers on XXXX, over territory. our specialists drive average XXX added territory. optimizing as will support. the of business of of that last $X.X managing revenue. million specialists By two in generated our X.X expect year. year. penetration and clinical territory, compares case end over and average within this XX education X.X are to the QX We approximately In in territory and average managers accounts between those ratio revenue XX training, currently approximately to territory the QX and the on XXX we and we $X of have aspects accounts launching the The clinical focus specialists XXXX territories of and primarily
our our we each expect grow enables business territory productivity while It territory with will does today. average to of the than territory As also average closely XXXX that having launching our will QX all fewer new of additional year, we increase have account. will that also products peripheral next coronary support to work service, more vice result in clinical we and specialists so The of can which increased ensure in substantially territories ratio in versa. territories accounts and team physicians the revenue
and progress adoption coronary In have see hospital continued Using both and addition new peripheral impact reimbursement. for US business structure, technologies. The procedure to expect the as expanding sales we the on tactics economics evolving physicians of to organizational an an on acceleration MX on a the in average product accelerate daily I sales seen new product of analog, with this was have noted each economics. based previously the of improved growth coupled that quarter we the family year the launch US. This hospital
involving pass-through is access procedures. transitional which this With procedure of device, IVL an hospital are reimbursed outpatient cost cost the hospital's Currently, payments CX purchase to past facilitate the under reimbursement the This January, helped catheter. $X,XXX coronary has change on cost a to for an to gathers increased clearly catheters IVL payment while offset the device. by to data CMS is the of intended the IVL IVL which coronary $X,XXX, than above-the-knee greater
pass-through peripheral. transitional should we incremental the path of for cost device. a to procedures The coronary that exceed to are on to reimbursement is beyond involving scenario, program long-term hospitals look similar the we IVL As payments the eventual the
the We situation, the stenting cost payment cost expect program above-the-knee be for support to to coronary would a procedures TPT the procedure. compared $X,XXX greater from purchase to than will for an that catheter. payment this standard our incremental the IVL hospitals CX a Similar incremental payment data to
when pleased was professional we level using cited fee, to incremental enable XXXX. CPT code Turning to starting IVL receive one the a physicians IVL. should are This physician that in coronary fees
our in a hospital penetration economics deeper footprint product both the at we with payments improved larger Outside and fees. of for are IVL. in to the that we fortunate for physician US, a very and CX+ of the enable new US, physician of will hospitals Japan have the ahead looking will coronary in So field a have and set strong launch outset
We reimbursement are in on also other countries. working
in Japan. Although, less predictable they to be tend
the an reimbursement prove we growth. for tailwind future any would if it uncertain country, While can incremental in be
their Our mentality and customers it highest to have an have IVL-first calcified quickly treating behaviors PCI. already comes volume when changed
will that to hope turn the mentality financials. call we will customer above, discussed review every I an efforts have With the comes now calcified when Dan IVL-first it the that, PCIs. to With to
